Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Shares Shorted: Short Interest Up 157.8% in September

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 526 shares, a growth of 157.8% from the September 15th total of 204 shares. Based on an average daily trading volume, of 94 shares, the days-to-cover ratio is presently 5.6 days. Currently, 0.0% of the company’s stock are sold short.

Orion OYJ Stock Performance

ORINY stock opened at $46.65 on Wednesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The business has a 50-day moving average price of $45.50 and a 200 day moving average price of $41.20. The company has a market capitalization of $13.17 billion, a P/E ratio of 19.20 and a beta of 0.07. Orion OYJ has a 1-year low of $30.89 and a 1-year high of $48.79.

Orion OYJ (OTCMKTS:ORINY) last released its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share for the quarter. The company had revenue of $606.38 million during the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%.

Orion OYJ Company Profile

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.

The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.